# EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)

> **NCT00230568** · PHASE4 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 100 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Aricept

## Key facts

- **NCT ID:** NCT00230568
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-04
- **Final completion:** 2007-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00230568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00230568, "EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00230568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*